These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34151817)

  • 1. Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease.
    Targum SD; Fosdick L; Drake KE; Rosenberg PB; Burke AD; Wolk DA; Foote KD; Asaad WF; Sabbagh M; Smith GS; Lozano AM; Lyketsos CG
    J Alzheimers Dis; 2021; 82(3):1243-1257. PubMed ID: 34151817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.
    Lozano AM; Fosdick L; Chakravarty MM; Leoutsakos JM; Munro C; Oh E; Drake KE; Lyman CH; Rosenberg PB; Anderson WS; Tang-Wai DF; Pendergrass JC; Salloway S; Asaad WF; Ponce FA; Burke A; Sabbagh M; Wolk DA; Baltuch G; Okun MS; Foote KD; McAndrews MP; Giacobbe P; Targum SD; Lyketsos CG; Smith GS
    J Alzheimers Dis; 2016 Sep; 54(2):777-87. PubMed ID: 27567810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial.
    Ponce FA; Asaad WF; Foote KD; Anderson WS; Rees Cosgrove G; Baltuch GH; Beasley K; Reymers DE; Oh ES; Targum SD; Smith GS; Lyketsos CG; Lozano AM;
    J Neurosurg; 2016 Jul; 125(1):75-84. PubMed ID: 26684775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.
    Leoutsakos JS; Yan H; Anderson WS; Asaad WF; Baltuch G; Burke A; Chakravarty MM; Drake KE; Foote KD; Fosdick L; Giacobbe P; Mari Z; McAndrews MP; Munro CA; Oh ES; Okun MS; Pendergrass JC; Ponce FA; Rosenberg PB; Sabbagh MN; Salloway S; Tang-Wai DF; Targum SD; Wolk D; Lozano AM; Smith GS; Lyketsos CG
    J Alzheimers Dis; 2018; 64(2):597-606. PubMed ID: 29914028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep brain stimulation for the treatment of Alzheimer disease and dementias.
    Laxton AW; Lozano AM
    World Neurosurg; 2013; 80(3-4):S28.e1-8. PubMed ID: 22722036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease.
    Scharre DW; Weichart E; Nielson D; Zhang J; Agrawal P; Sederberg PB; Knopp MV; Rezai AR;
    J Alzheimers Dis; 2018; 62(2):621-633. PubMed ID: 29400666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Brain Stimulation Influences Brain Structure in Alzheimer's Disease.
    Sankar T; Chakravarty MM; Bescos A; Lara M; Obuchi T; Laxton AW; McAndrews MP; Tang-Wai DF; Workman CI; Smith GS; Lozano AM
    Brain Stimul; 2015; 8(3):645-54. PubMed ID: 25814404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep brain stimulation for dementias.
    Xu DS; Ponce FA
    Neurosurg Focus; 2018 Aug; 45(2):E8. PubMed ID: 30064323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep brain stimulation of fornix in Alzheimer's disease: From basic research to clinical practice.
    Liu Z; Shu K; Geng Y; Cai C; Kang H
    Eur J Clin Invest; 2023 Aug; 53(8):e13995. PubMed ID: 37004153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying the progression of Alzheimer's and Parkinson's disease with deep brain stimulation.
    Jakobs M; Lee DJ; Lozano AM
    Neuropharmacology; 2020 Jul; 171():107860. PubMed ID: 31765650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Alzheimer disease clinical trial outcomes based on age of the participants.
    Schneider LS; Kennedy RE; Wang G; Cutter GR
    Neurology; 2015 Mar; 84(11):1121-7. PubMed ID: 25681452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease.
    Sabbagh M; Sadowsky C; Tousi B; Agronin ME; Alva G; Armon C; Bernick C; Keegan AP; Karantzoulis S; Baror E; Ploznik M; Pascual-Leone A
    Alzheimers Dement; 2020 Apr; 16(4):641-650. PubMed ID: 31879235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of deep brain stimulation of the anterior nucleus of thalamus, entorhinal cortex and fornix in a rat model of Alzheimer's disease.
    Zhang C; Hu WH; Wu DL; Zhang K; Zhang JG
    Chin Med J (Engl); 2015 May; 128(9):1190-5. PubMed ID: 25947402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic deep brain stimulation in an Alzheimer's disease mouse model enhances memory and reduces pathological hallmarks.
    Mann A; Gondard E; Tampellini D; Milsted JAT; Marillac D; Hamani C; Kalia SK; Lozano AM
    Brain Stimul; 2018; 11(2):435-444. PubMed ID: 29246746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Brain Stimulation as an Emerging Therapy for Cognitive Decline in Alzheimer Disease: Systematic Review of Evidence and Current Targets.
    Picton B; Wong J; Lopez AM; Solomon SS; Andalib S; Brown NJ; Dutta RR; Paff MR; Hsu FP; Oh MY
    World Neurosurg; 2024 Apr; 184():253-266.e2. PubMed ID: 38141755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic treatment of memory decline in Alzheimer's disease by deep brain stimulation: a feasibility study.
    Fontaine D; Deudon A; Lemaire JJ; Razzouk M; Viau P; Darcourt J; Robert P
    J Alzheimers Dis; 2013; 34(1):315-23. PubMed ID: 23168448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic fornix deep brain stimulation in a transgenic Alzheimer's rat model reduces amyloid burden, inflammation, and neuronal loss.
    Leplus A; Lauritzen I; Melon C; Kerkerian-Le Goff L; Fontaine D; Checler F
    Brain Struct Funct; 2019 Jan; 224(1):363-372. PubMed ID: 30341742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).
    Wessels AM; Dowsett SA; Sims JR
    J Prev Alzheimers Dis; 2018; 5(1):15-20. PubMed ID: 29405227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.